clinical trial · NCT07669077
A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
Janssen Research & Development, LLC·phase1·recruiting·n = 8
HealthyNipocalimabBreast Milk Sampling
brief summary
The main purpose of this study is to assess the concentrations of nipocalimab (pharmacokinetics \[PK\]) in the breast milk after administration of a single dose of nipocalimab into the vein, in healthy lactating women.
started
Jun 23, 2026
primary completion
Feb 16, 2027
completion
Feb 16, 2027
last updated
Jul 31, 2026
official title
A Phase 1, Open-Label, Lactation Study to Assess Concentrations of Nipocalimab in Breast Milk of Healthy Lactating Women
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol